STOCK TITAN

Stem Inc Financials

STEM
FY2025 annual
Revenue $156.3M +8.1% YoY
Net Income $137.8M +116.1% YoY
EPS (Diluted) -$9.18 +91.3% YoY
Free Cash Flow Not reported for FY2025
Source SEC Filings (10-K/10-Q) Data as of Jun 30, 2026 Currency USD FYE December

Stem Inc (STEM) reported $156.3M in revenue for fiscal year 2025, up 8.1% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI STEM FY2025

Stem’s reported FY2025 profit masks a still-lossmaking operating core being rebuilt through a sharp margin reset.

FY2025’s reported profit of $137.8M did not come from a fully repaired operating engine, because operating income was still -$55.7M. The stronger cash conversion and slight positive operating cash flow of $6.9M show the business stopped consuming cash the way it had a year earlier, but they still do not reconcile with a net margin of 88.2%.

FY2025 revenue was $156.3M, only modestly above FY2024’s $144.6M. Gross margin, however, swung to 38.4% from -7.7%, which points to a cost-base or mix reset rather than scale doing the work; the business sold through a much less punitive cost structure.

The balance sheet is still compressed: total assets are down to $308.9M from $1.36B in FY2023, and liabilities still exceed assets. A 0.9x current ratio plus negative equity means the operating improvement has not yet rebuilt much cushion for working capital or creditor support.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 25 / 100
Financial Health Score 25/100
Scored as: Utilities peer group

Scored against utilities for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Stem Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
7
Growth
1
Leverage
74
Liquidity
63
Cash Flow
0

Not available for Stem Inc, and counted as zero in the overall score.

Returns
3
Altman Z-Score Distress
-6.82

Stem Inc scores -6.82, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($54.5M) relative to total liabilities ($557.9M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
5/8

Stem Inc passes 5 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.

Earnings Quality Low Quality
0.05x

For every $1 of reported earnings, Stem Inc generates $0.05 in operating cash flow ($6.9M OCF vs $137.8M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage At Risk
N/A

Stem Inc reported an operating loss of $55.7M against $23.9M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$156.3M
YoY+8.1%
5Y CAGR+33.9%

Stem Inc generated $156.3M in revenue in fiscal year 2025. This represents an increase of 8.1% from the prior year.

EBITDA
-$10.7M
YoY+98.6%

Stem Inc's EBITDA was -$10.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 98.6% from the prior year.

Net Income
$137.8M
YoY+116.1%

Stem Inc reported $137.8M in net income in fiscal year 2025. This represents an increase of 116.1% from the prior year.

EPS (Diluted)
-$9.18
YoY+91.3%

Stem Inc earned -$9.18 per diluted share (EPS) in fiscal year 2025. This represents an increase of 91.3% from the prior year.

Cash & Balance Sheet

Cash & Debt
$48.9M
YoY-13.1%
5Y CAGR+47.8%

Stem Inc held $48.9M in cash as of fiscal year 2025; long-term debt is not reported for that period.

Shares Outstanding
8M
YoY+4.3%

Stem Inc had 8M shares outstanding in fiscal year 2025. This represents an increase of 4.3% from the prior year.

Free Cash Flow

Not reported for fiscal year 2025.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Gross Margin
38.4%
YoY+46.0pp
5Y CAGR+49.1pp

Stem Inc's gross margin was 38.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 46.0 percentage points from the prior year.

Operating Margin
-35.6%

Stem Inc's operating margin was -35.6% in fiscal year 2025, reflecting core business profitability. No change is given against fiscal year 2024: its reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Net Margin
88.2%

Stem Inc's net profit margin was 88.2% in fiscal year 2025, showing the share of revenue converted to profit. No change is given against fiscal year 2024: its reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Return on Equity

Not reported for fiscal year 2025.

Capital Allocation

R&D Spending
$35.3M
YoY-31.2%
5Y CAGR+17.2%

Stem Inc invested $35.3M in research and development in fiscal year 2025. This represents a decrease of 31.2% from the prior year.

Share Buybacks

Not reported for fiscal year 2025.

Capital Expenditures

Not reported for fiscal year 2025.

STEM Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

STEM annual income statement
MetricTTMFY25FY24FY23FY22FY21FY20FY19
Revenue$148.0M$156.3M+8.1%$144.6M-68.7%$461.5M+27.1%$363.0M+185.0%$127.4M+250.8%$36.3M+106.9%$17.6M
Cost of Revenue$86.7M$96.3M-38.1%$155.6M-66.0%$457.9M+38.8%$329.9M+161.6%$126.1M+213.6%$40.2M+93.2%$20.8M
Gross Profit$61.4M$60.0M+642.2%-$11.1M-401.7%$3.7M-88.9%$33.1M+2553.7%$1.2M+131.9%-$3.9M-20.0%-$3.3M
R&D Expenses$27.0M$35.3M-31.2%$51.3M-9.2%$56.5M+47.5%$38.3M+68.6%$22.7M+42.5%$15.9M+8.4%$14.7M
SG&A Expenses$46.0M$51.6M-41.4%$88.1M+17.6%$74.9M-2.7%$77.0M+85.0%$41.6M+183.2%$14.7M+18.4%$12.4M
Operating Income-$43.1M-$55.7M+93.4%-$839.5M-368.1%-$179.3M-36.8%-$131.1M-57.8%-$83.1M-68.2%-$49.4M-3.2%-$47.9M
Interest Expense$30.4M$23.9M+30.8%$18.3M+22.1%$15.0M+43.1%$10.5M-39.8%$17.4M-16.4%$20.8M+65.8%$12.5M
Income Tax$128K$536K+61.4%$332K-23.3%$433K+102.9%-$15.2M$0-100.0%$5K-16.7%$6K
Net Income-$73.0M$137.8M+116.1%-$854.0M-508.3%-$140.4M-13.2%-$124.1M-22.6%-$101.2M+35.2%-$156.1M-162.8%-$59.4M
EPS (Diluted)-$9.18+91.3%-$105.80-486.1%-$18.05-$0.81+15.6%-$0.96-$4.13-173.5%-$1.51

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

STEM Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

STEM annual balance sheet
MetricFY25FY24FY23FY22FY21FY20FY19
Total Assets$308.9M-29.4%$437.4M-67.8%$1.4B-4.6%$1.4B+19.3%$1.2B+479.0%$205.8M+9.5%$188.0M
Current Assets$100.1M-26.7%$136.6M-71.1%$473.0M-11.2%$532.8M-48.0%$1.0B+1977.7%$49.3M+71.1%$28.8M
Cash & Equivalents$48.9M-13.1%$56.3M-46.6%$105.4M+19.9%$87.9M-88.2%$747.8M+10671.8%$6.9M-46.1%$12.9M
Inventory$658K+56.3%$421K-98.4%$26.7M+218.4%$8.4M-63.1%$22.7M+9.0%$20.8M+482.2%$3.6M
Accounts Receivable$38.4M-35.3%$59.3M-80.4%$302.8M+35.7%$223.2M+261.8%$61.7M+354.6%$13.6M+105.0%$6.6M
Goodwill$0$0-100.0%$547.2M+0.1%$546.6M+31298.6%$1.7M+0.1%$1.7M+2.6%$1.7M
Total Liabilities$557.9M-33.2%$835.2M-10.2%$930.3M+7.0%$869.7M+66.0%$524.0M+36.7%$383.3M+80.3%$212.6M
Current Liabilities$110.6M-14.2%$128.8M-48.7%$251.1M-6.0%$267.0M+203.5%$88.0M-53.8%$190.5M+74.2%$109.3M
Total Equity-$249.4M+37.4%-$398.4M-193.5%$426.2M-22.7%$551.6M-17.4%$667.8M+476.4%-$177.4M-623.2%-$24.5M
Retained Earnings-$1.5B+8.5%-$1.6B-110.6%-$772.5M-22.2%-$632.1M-24.2%-$509.1M-24.8%-$407.8M-57.4%-$259.1M

Not reported in any period shown, so not listed: Long-Term Debt.

STEM Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

STEM annual cash flow statement
MetricTTMFY25FY24FY23FY22FY21FY20FY19
Operating Cash Flow$11.6M$6.9M+118.7%-$36.6M+82.3%-$207.4M-95.6%-$106.0M-4.7%-$101.3M-200.8%-$33.7M-13.5%-$29.7M
Investing Cash Flow-$4.5M-$6.6M-87.7%-$3.5M-102.6%$135.7M+124.9%-$544.4M-193.9%-$185.2M-1439.0%-$12.0M+74.0%-$46.4M
Financing Cash Flow-$9.1M-$7.6M+10.4%-$8.4M-109.4%$90.2M+1073.2%-$9.3M-100.9%$1.0B+2449.0%$40.3M-40.0%$67.2M

Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

STEM Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

STEM annual financial ratios
MetricFY25FY24FY23FY22FY21FY20FY19
Gross Margin38.4%+46.0pp-7.6%-8.4pp0.8%-8.3pp9.1%+8.1pp1.0%+11.8pp-10.8%+7.8pp-18.6%
Operating Margin-35.6%-580.6%-38.9%-2.7pp-36.1%+29.1pp-65.2%-136.0%-272.6%
Net Margin88.2%-590.7%-30.4%+3.8pp-34.2%+45.3pp-79.5%-430.0%-338.5%
Return on EquityN/AN/A-32.9%-10.5pp-22.5%-7.3pp-15.2%N/AN/A
Return on Assets44.6%+239.9pp-195.3%-184.9pp-10.3%-1.6pp-8.7%-0.2pp-8.5%+67.3pp-75.8%-44.2pp-31.6%
Current Ratio0.91-0.2x1.06-0.8x1.88-0.1x2.00-9.6x11.64+11.4x0.260.0x0.26
Debt-to-EquityN/AN/A2.18+0.6x1.58+0.8x0.78N/AN/A

Not reported in any period shown, so not listed: FCF Margin.

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin.

Note: Shareholder equity is negative (-$249.4M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.91), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Frequently Asked Questions

What is Stem Inc's annual revenue?

Stem Inc (STEM) reported $156.3M in total revenue for fiscal year 2025. This represents a 8.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Stem Inc's revenue growing?

Stem Inc (STEM) revenue grew by 8.1% year-over-year, from $144.6M to $156.3M in fiscal year 2025.

Is Stem Inc profitable?

Yes, Stem Inc (STEM) reported a net income of $137.8M in fiscal year 2025, with a net profit margin of 88.2%.

Stem Inc (STEM) reported diluted earnings per share of -$9.18 for fiscal year 2025. This represents a 91.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Stem Inc (STEM) had EBITDA of -$10.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Stem Inc (STEM) had a gross margin of 38.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Stem Inc (STEM) had an operating margin of -35.6% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Stem Inc (STEM) had a net profit margin of 88.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Stem Inc (STEM) generated $6.9M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Stem Inc (STEM) had $308.9M in total assets as of fiscal year 2025, including both current and long-term assets.

Stem Inc (STEM) invested $35.3M in research and development during fiscal year 2025.

Stem Inc (STEM) had 8M shares outstanding as of fiscal year 2025.

Stem Inc (STEM) had a current ratio of 0.91 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

Stem Inc (STEM) had a return on assets of 44.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Stem Inc (STEM) has negative shareholder equity of -$249.4M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Stem Inc (STEM) has an Altman Z-Score of -6.82, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Stem Inc (STEM) has a Piotroski F-Score of 5 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Stem Inc (STEM) has an earnings quality ratio of 0.05x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Stem Inc (STEM) reported an operating loss of $55.7M against $23.9M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Stem Inc (STEM) scores 25 out of 100 on our Financial Health Score, indicating weak standing within its utilities peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top